Join Dr. Richard McFarland, ARMI’s Chief Regulatory Officer, as he participates in a panel discussion on Cryopreservation Regulatory Considerations. Led by Professor Allison Hubel of EviaBio, this webinar is part of the CryoChats™ series, a monthly virtual roundtable dedicated to addressing cryopreservation challenges within the cell and gene therapy industry.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
